Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors while in the central nervous process, conolidine modulates alternate molecular targets. A Science Advances analyze uncovered that conolidine interacts Using the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide availability. By https://proleviateconolidinebenef75298.free-blogz.com/85758384/a-review-of-alternative-natural-pain-relief-to-replace-traditional-painkillers